Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 10, 2025
Reporting Period: Event date October 10, 2025
Business Context: The company is an emerging growth company incorporated in British Columbia, Canada, with common shares traded on The Nasdaq Stock Market LLC under the symbol "INM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely announces administrative details regarding an upcoming shareholder meeting.
Guidance, Outlook, and Management Commentary
Item 8.01 Other Events: On October 10, 2025, InMed Pharmaceuticals Inc. announced the meeting date, record date, and certain other information relating to its 2025 annual general and special meeting of shareholders. This announcement was made pursuant to a revised filing submitted to the System for Electronic Document Analysis and Retrieval ("SEDAR") in Canada.
Exhibits: The filing includes the SEDAR filing submitted on October 10, 2025 (Exhibit 99.1) and a Cover Page Interactive Data File (Exhibit 104).
Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this text.
Important Facts for Investors to Verify
- Verify the specific meeting date and record date for the 2025 annual general and special meeting of shareholders by reviewing the referenced SEDAR filing (Exhibit 99.1).
- Confirm the agenda and proposals to be voted on at the special meeting, as details are not included in this 8-K summary.
- Check for any subsequent filings regarding the outcome of the shareholder meeting.